Subscribe
One of our best-performing screens has bounced back
Our modified Dreman stock screen has been on a characteristically wild ride of late
What do Amazon, Meta, Sage and GSK have in common?
The past year has highlighted both the defects and qualities in two screens inspired by the recently retired quant legend
On recent form, there is one clear winner from this stockpicking head-to-head
After a solid 2022, our Inflation Busters screen now skews towards reliable investment trust dividend payers
Amid a volatile quarter for equities, the strengths of our six-in-one stock screen were blunted by its weaknesses
Our Great Expectations stock screen, one of a handful that held up well in 2022, now likes bank stocks
Despite its strong performance since early 2020, our quarterly blue-chip momentum screen has struggled lately with bumpy markets
Our stock screens鈥� collective performance was hit hard by the market鈥檚 struggles in 2022. Alex Newman, in his inaugural year tending to them, gives his thoughts.
